Various heterocyclic scaffolds have drawn special attention of medicinal chemists and hence, extensive efforts are being carried out in search of lead molecules related to it. Benzimidazole is an important pharmacophore owing to its inherent properties and therapeutic actions. These exhibit many biological activities like anticancer, anticonvulsant, antiHIV, antimicrobial and many more. Such biological applications of benzimidazole derivatives have attracted attention and stimulated new search for its novel derivatives with improved biological activities and these are being extensively studied. The present review includes rigorous literature survey on the search of biologically active benzimidazole ring linked and fused with other heteroaromatic systems.
Introduction
Heterocyclic compounds are very widely distributed in nature and are particularly important because of the wide variety of physiological activities associated with this class of substances. Several of the important compounds like alkaloids, antibiotics, chlorophyll, other plants pigments, amino acids, dyes, drugs, enzymes and genetic material contain heterocyclic rings 1 . Amongst the important heterocyclic compounds, benzimidazole has stimulated considerable interest because of its diversified biological activities. It is a fused aromatic imidazole ring system where a benzene ring is fused to the 4 and 5 positions of an imidazole ring. Benzimidazole is also known as 1, 3-benzodiazoles. It possesses both acidic and basic characteristics. The cyclic -NH-group present in benzimidazole is relatively strongly acidic and also weakly basic. These also have the capacity to form salts. Benzimidazole with unsubstituted -NH-groups, exhibit fast prototropic tautomerism instead of isomerism. 
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Boiling point >360°c
Solubility in water 1.70±01 g/l.
Benzimidazole is considered to be an important pharmacophore and a privileged structure in medicinal chemistry. Figure No.-14) as pharmacophore for antituberculor activity and compared against rifampicin. All compounds were screened for antimycobacterial activity against S. aureus, P. aeruginosa, E. coli and S. typhii. These derivatives which contained mono-or di-fluoro substitution at various position on phenyl ring showed better activity against the mycobacteria with >96% inhibition at 6.25 mg concentration.
Shingalapur, et. al 16 synthesized novel 5-(nitro/bromo) substituted-2-styryl benzimidazole derivatives. These compounds showed good antibacterial, antifungal and antitubercular activities against various strains of microbes and fungi. Compound ( Figure No.-14) showed good activity against M. tuberculosis strain. The moderately electron donating groups on phenyl ring were found to confer higher activity compared to electron withdrawing nitro derivatives. evaluated for cytotoxicity and antiviral activity against 10 types of RNA and DNA viruses in cell-based assay. Fifty-six of the tested compounds exhibited antiviral activity against one or more viruses, and thirty nine of them showed EC50 ≤ 10 µM against at least one virus. The 2-substituted anilinobenzimidazole derivatives were found to be more effective against more number of viruses. Compounds with nitro and chloro substitution exhibited lowest toxicity for the host cells. The very high cytotoxicity observed in some of these compounds may also warrant their evaluation as possible ant-proliferative agents. From SAR study they concluded that 2-pyridyl derivatives at 2-position are much better than 3-and 4-pyridyl derivatives. -23) containing Nsugar moiety only decreases the inflammation by 62% and 72%; respectively as compared to standard drug diclofenac (73%). Moreover these compounds act as ulcer inhibiting agents when tested in alcohol-induced gastric ulcer in mice and pylorus ligation-induced gastric ulcer in rats. They concluded in SAR that compound lacking sugar moiety exhibited mild anti-ulcer activity. Also, the compounds with moderate electron donating groups in the pyridine moiety were found to be much active as anti-inflammatory agents.
Gaba M et. al 24 have reported the synthesis of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives ( Figure No.-24 ). These compounds were tested invivo for anti-inflammatory and analgesic activities by carrageenan-induced rat paw oedema model and acetic acid-induced writhing method in albino mice; respectively. It was found that anti-inflammatory and analgesic activity was comparable to that of standard drug indomethacin and aspirin; respectively. These compounds also have low ulcerogenic properties than indomethacin. 
R= H/OH
Antialzeimer's Activity Jain P et. al 27 have designed the synthesis of 6-O-linked series of benzimidazoles by molecular modelling on roscovitine which is a moderately selective CDK5/p25 inhibitor, used in the treatment of Alzheimer's disease. This disease is caused either by extra neuronal accumulation of β-amyloid (Aβ) or by intra neuronal deposition of neurofibrillary tangles (NFTs). The major component of these NFTs is the structural protein tau. It was found that CDK5 mediated tau hyperphosphorylation at Ser202 and/or Thr205.causes both NFT formation and the loss of cytoskeletal integrity that facilitates Aβ mediated apoptotic cell death. They replaced the amino substituted adenine core of roscovitine by 6-O-substituted Letters, 2006 Letters, , 16, 1995 Letters, -1999 
